18th Jun 2019 14:03
18 June 2019
Diurnal Group plc
("Diurnal" or the "Company")
Director Dealings
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces the following subscriptions for shares by Directors or persons closely associated with them in its recent Placing on the same terms as other investors, as disclosed in the circular issued on 28 May 2019:
Martin Whitaker, Chief Executive Officer, subscribed for 19,230 ordinary shares of 5 pence each in Diurnal Group plc ("Ordinary Shares") at a price of 26 pence per Ordinary Share. Following the transaction Martin Whitaker has a total interest of 69,959 Ordinary Shares, representing 0.08% of the total voting rights in the Company.
Richard Bungay, Chief Financial Officer, subscribed for 19,230 Ordinary Shares at a price of 26 pence per Ordinary Share. Following the transaction Richard Bungay has a total interest of 21,452 Ordinary Shares, representing 0.02% of the total voting rights in the Company.
Peter Allen, Chairman, subscribed for 84,722 Ordinary Shares at a price of 26 pence per Ordinary Share. Following the transaction Peter Allen has a total interest of 169,444 Ordinary Shares, representing 0.20% of the total voting rights in the Company.
John Goddard, Non-executive Director, subscribed for 38,461 Ordinary Shares at a price of 26 pence per Ordinary Share. Following the transaction John Goddard has a total interest of 103,476 Ordinary Shares, representing 0.12% of the total voting rights.
Alan Raymond, Non-executive Director, and his wife, Lynne Raymond, subscribed respectively for 19,231 and 19,230 Ordinary Shares at a price of 26 pence per Ordinary Share. Following the transaction Alan Raymond and his wife have a total interest of 67,349 Ordinary Shares, representing 0.08% of the total voting rights in the Company. 39,119 Ordinary Shares are held by Alan Raymond and 28,330 Ordinary Shares are held by his wife.
Capitalised terms used but not otherwise defined in this announcement bear the meaning ascribed to them in the circular issued by the Company on 28 May 2019.
For further information, please visit www.diurnal.co.uk or contact: | |
Diurnal Group plc | +44 (0)20 3727 1000 |
Martin Whitaker, Chief Executive Officer | |
Richard Bungay, Chief Financial Officer | |
Panmure Gordon (UK) Limited (NOMAD and Joint Broker) | +44 (0) 20 7886 2500 |
Corporate Finance: Freddy Crossley, Emma Earl | |
Corporate Broking: James Stearns | |
Cantor Fitzgerald Europe (Joint Broker) | +44 (0)20 7894 7000 |
Corporate Finance: Philip Davies, William Goode, Michael Boot | |
Healthcare Equity Sales: Andrew Keith | |
FTI Consulting (Investor Relations) | +44 (0)20 3727 1000 |
Simon Conway | |
Victoria Foster Mitchell | |
Notes to Editors
About Diurnal Group plc
Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.
For further information about Diurnal, please visit www.diurnal.co.uk
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Martin Whitaker Richard Bungay Peter Allen John Goddard Alan Raymond Lynne Raymond | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chief Executive Officer Chief Financial Officer Chairman Non-Executive Director Non-Executive Director Wife of Non-Executive Director | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Diurnal Group plc | |||
b)
| LEI
| 213800I2HNUNZN1LDH29 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 5 pence each in Diurnal Group plc | |||
Identification code | GB00BDB6Q760 | ||||
b)
| Nature of the transaction
| Subscription for shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
26p | 19,230 | ||||
26p | 19,230 | ||||
26p | 84,722 | ||||
26p | 38,461 | ||||
26p | 19,231 | ||||
26p | 19,230 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | - 200,104 | ||||
- Price | - £52,028.08 | ||||
e)
| Date of the transaction
| 18 June 2019 | |||
f)
| Place of the transaction
| Outside a trading venue | |||
Related Shares:
DNL.L